Ann: Expanded collaboration with Siemens Healthineers to US, page-78

The potential prize ahead of us, remains the same.
But yes, time can have utilized that capital elsewhere.

The gravy train of potential forward earnings from volumes of NPs used in both MRX and MRI.
The de-risking of MRI contrast, is a massive step forward, in terms of initial capital of hardware.
The patient safety demonstrated use with MRX.
I would argue, that in the scales of lady justice, the balance of things has improved, in lou of time spent.

You have to consider in one hand of lady justice there was risk, that has now been lightened. In the other, time spent.

But both MRX and MRI are still to compliment each other. We have simply identified a less capital expensive initial MRI path ahead. Does not remove the additional application of MRX in the ultimate ascent.